Moderna's vaccine against COVID-19 was 96% effective in trials with children and adolescents aged 12 to 17 years.
According to the pharmacist, the immunization was well tolerated and has not raised any serious concerns so far. May 6, 2021
Now you can see non-English news...
2021-05-08T00:49:43.903Z
Moderna's vaccine against COVID-19 was 96% effective in trials with children and adolescents aged 12 to 17 years. According to the pharmacist, the immunization was well tolerated and has not generated any serious concern so far.
Moderna's vaccine against COVID-19 was 96% effective in trials with children and adolescents aged 12 to 17 years.
According to the pharmacist, the immunization was well tolerated and has not raised any serious concerns so far. May 6, 2021
© Communities 2019 - Privacy
The information on this site is from external sources that are not under our control.